Evidence map›Paper›PMID 42350479›Full record

ArticleScientific reports2026

Green NiO nanoparticle catalyzed synthesis of novel triazolopyrimidine derivatives with physicochemical characterization and computational evaluation for gout therapy.

Doaa A Elsayed, Wesam S Shehab, Abdulrahman E Mesbah, Ahmed F El-Sayed, Sahar M Mousa, Gehan T El-Bassyouni, Basant Farag

Abstract read
In one paragraph

Article in Scientific reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Doaa A ElsayedDepartment of Chemistry, Faculty of Science, Zagazig University, Zagazig, 44519, Egypt. doaaatef641995@gmail.com.ORCID 0000-0001-8139-8548
Wesam S ShehabDepartment of Chemistry, Faculty of Science, Zagazig University, Zagazig, 44519, Egypt. dr.wesamshehab@gmail.com.ORCID 0000-0002-5246-3491
Abdulrahman E MesbahDepartment of Chemistry, Faculty of Science, Mansoura University, Mansoura, 35516, Egypt.ORCID 0009-0000-3080-4454
Ahmed F El-SayedMicrobial Genetics Department, Biotechnology Research Institute, National Research Center, Giza, Egypt.
Sahar M MousaInorganic Chemistry Department, National Research Center, 33 El-Buhouth St., Dokki, 12622, Cairo, Egypt.ORCID 0000-0003-3790-5084
Gehan T El-BassyouniRefractories, Ceramics and Building Materials Department, National Research Centre, 33 El-Buhouth St., Dokki, 12622, Cairo, Egypt.ORCID 0000-0001-8438-0570
Basant FaragDepartment of Chemistry, Faculty of Science, Zagazig University, Zagazig, 44519, Egypt.ORCID 0000-0002-5513-9945

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

A novel series of triazolopyrimidine derivatives (5a-d and 6a-c) was synthesized via a green NiO nanoparticle-catalyzed protocol under mild conditions, affording the target compounds in good to excellent yields. The NiO nanoparticles exhibited high catalytic efficiency, attributed to their nanoscale features and porous structure, as confirmed by physicochemical characterization. Structural elucidation of the synthesized compounds was achieved using standard spectroscopic techniques. Computational studies, including density functional theory and molecular docking, were employed to evaluate the reactivity and potential multi-target activity of the compounds against key proteins involved in gout pathogenesis. The results revealed that selected derivatives exhibited favourable binding affinities toward multiple inflammatory targets, supported by stable protein-ligand interactions in molecular dynamics simulations. These findings suggest that the synthesized compounds may serve as potential multi-target candidates for gout therapy and warrant further biological investigation.

Indexed as

GoutMetal NanoparticlesNickelPyrimidinesTriazolesCatalysisGreen Chemistry TechnologyHumansMolecular Docking SimulationMolecular Dynamics SimulationNickelnickel monoxidePyrimidinesTriazolesADMETChalcone derivativesDFTDockingDynamics (MD) simulationsGoutNiO-nanocatalyzed

Identifiers

PMID42350479
PMCPMC13304161

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.